Ukususela ngomhla wama-24 ukuya kumhla wama-26 kuJuni ngo-2025, i-CPhI ye-23 yase-China yabanjwa ngempumelelo kwiZiko leMiboniso yeZizwe ngezizwe laseShanghai! UMongameli we-JYMed uMnu. Iqela lizibandakanye ngokuthe ngqo nomjikelo opheleleyo wobomi bamachiza e-GLP-1 peptide, enika ulwazi lweengcali kwiindawo ezintandathu eziphambili: i-R&D, i-CMC, imveliso, ulawulo lomgangatho, ikhonkco lokubonelela, kunye nophuhliso lweshishini.
Ngexesha leentlanganiso kunye nabathengi, i-JYMed ibonise ukunyaniseka kunye neziphumo ezomeleleyo. Iqela lethu lesigqeba lalibandakanyeke ngokunzulu, linikezela ngenkxaso yengcali ekupheleni kokuphela kunye nokuhlola amathuba okubambiswano ubuso ngobuso.Ngokuseka ikhonkco lokuphendula ngokuthe ngqo elikhokelwa ngabaphathi abaphezulu, sajongana nemingeni evela kwiibhotile zenkqubo ukubonelela ngeengozi ngeemodeli eziguquguqukayo, ezilungelelanisiweyo zentsebenziswano-ukuguqula intlanganiso nganye ibe yindawo yokuthintela isicwangciso esakhiwe kwi-trust.
Apho siqhubela phambili siphawula kungekhona kuphela ukuphela kwekhonkco le-peptide kodwa isiqalo sempilo engcono.Ngobuchule obutsha bezobuchwepheshe njenge-oar yethu kunye nempumelelo yabathengi njengekhampasi yethu, i-JYMed izimisele ukuba yinkokeli yehlabathi kwiinkonzo ze-peptide ze-CRDMO.Sijonge phambili kwixabiso lokudala ngokubambisana, ukuphumeza intsebenziswano yokuphumelela, kunye negalelo kuphuhliso lwehlabathi jikelele lwe-peptide.
Malunga JYMed
I-JYMed yinkampani yamayeza eqhutywa yisayensi egxile ekuphuhliseni, ekuveliseni, nasekurhwebeni kweemveliso ezisekwe kwipeptide. Sinikezela ngeenkonzo ze-CDMO zokuphela- ukuya esiphelweni kumayeza, ezozithambiso, kunye namaqabane onyango lwezilwanyana kwihlabathi liphela.
Iipotifoliyo zethu zemveliso ziquka uluhlu olubanzi lwe-peptide APIs, kuquka i-Semaglutide kunye ne-Tirzepatide, zombini eziye zagqiba ngempumelelo iifayili ze-US FDA DMF.
Ingalo yethu yokuvelisa, i-Hubei JXBio, isebenza kwimizila yemveliso ye-peptide API efikelela kwimigangatho ye-cGMP evela kuzo zombini i-US FDA kunye ne-NMPA yaseTshayina. Isiza sinemizila ye-10 emikhulu kunye ne-pilot-scale-scale kwaye ixhaswa yi-QMS eyomeleleyo kunye nesakhelo se-EHS esibanzi.
I-JXBio iphumelele uphicotho lwe-GMP yi-FDA yase-US kunye ne-NMPA yaseTshayina kwaye yamkelwa ziinkampani ezikhokela amayeza ngokuzinikela kwayo kukhuseleko, umgangatho, kunye noxanduva lokusingqongileyo.
IIMVELISO EZIPHAMBILI
MasiQhagamshele
Ukufunda ngakumbi ngezakhono zethu okanye ukucwangcisa intlanganiso ngexesha lomboniso:
•Global API & Cosmetic Imibuzo:+ 86-150-1352-9272
•Ubhaliso lwe-API kunye neeNkonzo zeCDMO (US & EU):+ 86-158-1868-2250
•I-imeyile: jymed@jymedtech.com
•Idilesi:Imigangatho ye-8 & 9, iSakhiwo 1, i-Shenzhen Biomedical Innovation Industrial Park, i-14 Jinhui Road, iSithili saseKengzi, iSithili sasePingshan, iShenzhen, eChina.
Ixesha lokuposa: Jul-05-2025
